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See original paper on page 2406One of the great advantages offered by ambulatory blood
pressure monitoring (ABPM) is the possibility to describe
BP patterns over 24 h under daily life conditions. This has
produced a deeper insight into BP physiology, as well as
into the association of certain diseases with characteristic
circadian BP profiles. Subsequent to the application of
the pioneering techniques for intra-arterial beat-by-beat
ABPM over 24 h [1], it has become clear that BP is far
from being maintained at a fixed level. Instead, BP shows
continuous and often marked fluctuations [2] with a
variety of time constants, ranging from a few seconds
to hours, days and months, as in the case of seasonal BP
fluctuations [3,4]. Analysis of 24-h ABPM data has
allowed a quantitative description of BP variability. This
is the case when considering all BP changes at the same
time, summarized by the standard deviation of the 24-h
average BP. This is also the case when focusing on
specific components contributing to overall BP variance,
such as the morning BP rise and the nocturnal BP fall
[3,5].
The BP fall occurring at the time of night sleep is among
the components of BP variability that have received the
greatest attention by both physiologists and clinicians.
The many studies investigating the mechanisms under-
lying these diurnal BP changes have highlighted the role
played by several factors, such as central neural influ-
ences related to sleep stages, with a major contribution by
the autonomic nervous system, humoral factors such as
corticosteroid hormones and the renin–angiotensin sys-
tem, and respiratory factors related to the mechanics of
ventilation and the accompanying changes in arterial
blood O2 and CO2 concentrations [3,6].
In 1988, O’Brien et al. [7] reported for the first time that
an abnormal circadian blood pressure profile with
decreased night-time dipping may lead to a higher riskopyright © Lippincott Williams & Wilkins. Unauth
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hypertensive cohorts [12–18] provided corroboration that
an elevated nocturnal blood pressure is a harbinger of an
unfavourable outcome. In spite of the apparent con-
cordance between these large-scale outcome studies
[8–18], several potential limitations require further
clarification with respect to the prognostic accuracy of
daytime versus night-time ambulatory blood pressure.
Many studies considered only fatal outcomes [8,9,16,17]
or did not have the power to study cause-specific cardio-
vascular endpoints [8,9,11,15]. Investigators dichoto-
mized the night-to-day blood pressure ratio, and applied
different definitions of dipping status or the daytime and
night-time intervals. Few reports formally compared the
predictive value of the blood pressure at night over and
beyond the daytime level. Finally, in predominantly
treated cohorts of hypertensive patients, antihyperten-
sive drug treatment attenuated the association between
outcome and blood pressure [13].
An additional important problem to consider in this
field is the reproducibility of BP changes between day
and night. Such a reproducibility and, as a direct con-
sequence, the reproducibility of patients’ classification
into dippers and nondippers is indeed still a matter of
lively debate. In this issue of the Journal, Hernandez-del
Rey et al. [19] provide additional data on this topic
originating from the National ABPM Registry of the
Spanish Society of Hypertension. This was done by
obtaining 48-h ABP recordings from 611 hypertensive
patients, 235 of whom were yet untreated, recruited
throughout Spain. The aim of the study was to investigate
the reproducibility of the circadian ABP pattern over a
48-h period, by comparing day–night BP changes
observed during the first 24-h period of ABPM with those
observed during the second 24-h period, as well as with
the mean day–night changes over the entire 48-h record-
ing. The percentage of patients classified as nondipper
for the first 24 h, the second 24 h and, on average, over the
entire 48-h period was 47, 50 and 48%, respectively.
When comparing the first with the second 24-h intervals,
24% of patients switched their classification from dipper
to nondipper, or vice versa, with consistent results, when
separately considering systolic and diastolic BP or treated
and untreated patients. The conclusion drawn by the
authors is that the categorization of essential hyperten-
sive patients, investigated in a general practice setting,
into dippers or nondippers based on a single 24-h ABPM
is only moderately reproducible because one out of five
patients changes her/his circadian BP profile classificationorized reproduction of this article is prohibited.
C2378 Journal of Hypertension 2007, Vol 25 No 12over the next 24 h. Concerning the question of whether
a longer duration of ABPM (e.g. 48 h) might provide
more reliable data on day–night BP changes, the authors
suggested that the average day–night BP difference
derived from two 24-h periods may be more reproducible
than that quantified by the analysis of one 24-h period
only. A precise demonstration of this, however, is not
provided in their study, in which no repetition of 48-h
ABP recordings over time is available, whereas the com-
parison made by the authors between the day–night BP
changes during the first 24 h and those averaged over 48 h
is methodologically questionable [19].
The reproducibility of circadian BP profiles has been
investigated in a number of previous studies (Table 1)
[19–30], with differing results that were influenced by a
number of factors. These include the methods selected to
assess the day–night BP changes, the focus on treated or
untreated subjects, the patients’ concomitant clinical
conditions, and the degree of daytime physical activity
[31] or the quality of night-time sleep [24], although
controversial data have been published also on this issue
[32,33].
Chaves et al. [28] investigated the reproducibility of the
dipping status in 101 subjects, including both normoten-
sive and treated hypertensive patients, in whom 24-h
ABPM was performed three times at intervals of
8–15 days. When the dipper/nondipper status was
defined based on a predefined cut-off point (nocturnal
BP reduction higher or lower than 10% of daytime BP
levels, respectively), such a definition was poorly repro-
ducible in the subsequent recordings. Conversely, when
the percentage BP decline was analyzed as a continuous
rather than as categorical variable, the average nocturnal
BP fall was not different between recordings. Chaves
et al. [28] did not report comparisons between recordings
within individual subjects. Ben-Dov et al. [29] retrospec-
tively examined the reproducibility of BP dipping atopyright © Lippincott Williams & Wilkins. Unautho
Table 1 Reproducibility of nocturnal blood pressure fall
Study Type of patients
Palatini et al. (1994) [20] Hypertensive
James et al. (1995) [21] Hypertensive elderly
Mochizuki et al. (1998) [22] Hypertensive
Omboni et al. (1998) [23] Hypertensive untreated or treated
Manning et al. (2000) [24] Hypertensive
Covic et al. (2000) [25] Haemodialysis
Peixoto et al. (2000) [26] Haemodialysis
Rahmana et al. (2005) [27] Haemodialysis
Chaves et al. (2005) [28] Normotensive and treated hypertensive
Ben-Dov et al. (2005) [29] Hypertensive accounting for sleep and awake
Cuspidi et al. (2006) [30] Hypertensive with or without diabetes
Hernandez-del Rey (2007) [19] Hypertensive general practice
ABPM, ambulatory blood pressure monitoring.night in clinical practice patients with duplicated ABPM
by accounting for the sleep–awake states, rather than by
relying on arbitrary day–night definitions. They found
that systolic BP dipping was equally reproducible as the
average 24-h BP, with 66% of patients showing a repro-
ducible dipping status. In their study, awake BP included
also BP recorded during night-time arousals, whereas
sleep BP also included BP recorded during afternoon
naps. In a number of other studies, however, a limited
reproducibility was reported for nocturnal BP fall in
hypertensive patients. Palatini et al. [20] analyzed data
from 508 patients included in the HARVEST trial, com-
paring BP dipping observed in two ambulatory recordings
performed 3 months apart, and concluded that the repro-
ducibility of night-time BP dipping was poor. Mochizuki
et al. [22] assessed the day–night BP changes in 253
never-treated hypertensive patients and found a 29%
variability in the dipper/nondipper definition between
repeated recordings, whereas Manning et al. [24] reported
a variability of approximately 50%. James et al. [21]
reported that more than one-third of 42 elderly hyper-
tensive patients modified their dipping status over a
2-month period. Omboni et al. [23] found that approxi-
mately 40% of hypertensive patients included in
SAMPLE (Study on Ambulatory Monitoring of Pressure
and Lisinopril Evaluation) changed their dipping pattern
when ABPM was repeated after 1 year. Finally, the
reproducibility of nocturnal BP dipping can be impor-
tantly affected by other diseases in the presence of
hypertension. Rahmana et al. [27] investigated 59 hemo-
dialysis patients, in whom the ambulatory BP was mon-
itored for 44 h on three occasions, at baseline and after
6 and 12 months, respectively. The overall reproducibil-
ity of the dipper/nondipper classification was poor: 55%
of patients maintained their original classification at
6 months and 70% at 12 months. However, when the
nondipper status was considered separately, 92% of ini-
tially nondipper patients remained nondippers at 6 and at
12 months. The authors concluded that haemodialysisrized reproduction of this article is prohibited.
Reproducibility
Poor
65%
71%
60%
50%
As above
57%
55–70% (6–12 months)
Nondipping 92%
Poor (categorical analysis)
High (considering blood pressure fall as a continuous variable)
periods 66%
84.6% (dipper), 91.3% (nondipper) in diabetic hypertensive
49.2% (dipper), 29.5% (nondipper) in nondiabetic hypertensive
76% (24-h ABPM)
89% (48-h ABPM)
CFeatures of circadian BP changes Parati and Staessen 2379patients identified as nondippers consistently reproduce
the same circadian profile over long-term follow-up,
which is in agreement with the data provided by Covic
et al. [25], but not in line with the results obtained by
Peixoto et al. [26]. The latter study showed a reproduci-
bility of nondipping of between 53 and 78% in the same
type of patients. Similar results on a high short-term
reproducibility of the nondipping pattern have been
shown by Cuspidi et al. [30] in 36 hypertensive patients
with type 2 diabetes, as compared with 61 untreated
nondiabetic hypertensive subjects, by performing 24-h
ABPM twice over a 4-week period. Some 91.3% of
diabetic hypertensive patients, who were nondippers at
the first recording, showed the same circadian pattern
during the second ABPM, with the reproducibility of the
dipping pattern being 84.6%. Conversely, in nondiabetic
hypertensive patients, reproducible dipper and non-
dipper patterns were observed only in 49.2 and 29.5%
of patients, respectively. The practical conclusion of
the authors was that a nondipper pattern appears to be
reliable in diabetic subjects, even if assessed by a single
performance of 24-h ABPM, whereas repeated ABP
recordings should be recommended to define the circa-
dian BP pattern in a correct manner in nondiabetic
individuals.
An international consortium [34] recently reported risk
estimates independently associated with the daytime and
night-time BP in 7458 subjects (mean age¼ 56.8 years;
45.8% women), enrolled in prospective population stu-
dies in Denmark, Belgium, Japan, Sweden, Uruguay and
China. Median follow-up was 9.6 years. Adjusted for
daytime BP, night-time BP predicted total (n¼ 983;
P< 0.0001), cardiovascular (n¼ 387; P< 0.01) and non-
cardiovascular (n¼ 560; P< 0.001) mortality. Conversely,
adjusted for night-time BP, daytime BP predicted only
noncardiovascular mortality (P< 0.05), with lower blood
pressure levels being associated with increased risk. Both
daytime and night-time BP consistently predicted all
cardiovascular events (n¼ 943; P< 0.05) and stroke
(n¼ 420; P< 0.01). Adjusted for night-time BP, daytime
BP lost prognostic significance only for cardiac events
(n¼ 525; P 0.07). Adjusted for the 24-h BP, the night-
to-day BP ratio predicted mortality, but not fatal com-
bined with nonfatal events. Antihypertensive drug
treatment removed the significant association between
cardiovascular events and the daytime BP. Thus, in the
international database [34], the predictive accuracy of
the daytime and night-time BP and the night-to-day BP
ratio depended on the disease outcome under study and
differed for fatal outcomes compared to the composite of
fatal and nonfatal diseases [34]. For fatal endpoints,
night-time BP performed better than the daytime BP,
and the night-to-day BP ratio predicted mortality. By
contrast, for fatal combined with nonfatal outcomes, the
daytime BP performed equally as well as the night-time
BP and the night-to-day BP ratio lost its prognosticopyright © Lippincott Williams & Wilkins. Unauthaccuracy. Antihypertensive drug treatment was a major
confounder because patients with more severe hyperten-
sion and those with a history of cardiovascular compli-
cations were at the highest cardiovascular risk but, at the
same time, were also more likely to be treated. Hyper-
tensive patients take their medications during daytime
and the blood pressure-lowering activity often weans off
at night. This mechanism predictably leads to lower
daytime BP, higher night-time BP, and a diminished
night-to-day BP ratio.
Reverse causality might also contribute to the inconsis-
tency in the prediction of disease outcomes by the night-
time as opposed to the daytime BP. The international
consortium reported that reverse dippers, who had higher
night-time than daytime BP, were at the highest risk of
all-cause mortality [34]. In several studies [14,17,35],
reverse dippers not only were more frequently on anti-
hypertensive drug treatment [14,17], but also they were
older [14,17,35] or more likely to have a history of
diabetes mellitus [35] or previous cardiovascular disease
[14,35]. Moreover, similar to cardiovascular risk, the
night-to-day BP ratio also increases with advancing age
[36]. In the international database [34], participants with
a systolic night-to-day BP ratio of 1 or more were older
and therefore at higher risk of death, but they died at an
older age than those whose night-to-day ratio was normal
( 0.80 to < 0.90). Thus, reverse dipping might be a
marker rather than a cause of a worse outcome. The
inverse associations in the international database [34]
between noncardiovascular mortality and the daytime
BP and between total mortality and the daytime BP in
untreated subjects also supported the interpretation of
reverse causality.
In conclusion, the classification of patients into dippers
and nondippers depends heavily on arbitrary criteria, is
poorly reproducible, and has a different prognostic mean-
ing according to the disease outcome under study, the
prevailing 24-h BP level, and treatment status. We would
therefore recommend that, in future studies, any cat-
egorical results of the night-to-day BP ratio be supported
by continuous analyses adjusted for the 24-h BP and be
stratified for treatment status. Moreover, the available
evidence supports the concept that the ambulatory BP
should be recorded over the whole day, as both the night-
time and daytime BP levels carry prognostic information.
The 24-h BP level [37], rather than the dipping pattern,
should continue to inform clinical decisions.
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C2406 Original articleReproducibility of the circadian blood pressure pattern in
24-h versus 48-h recordings: the Spanish Ambulatory Blood
Pressure Monitoring Registry
Raquel Herna´ndez-del Reya, Montserrat Martin-Baranerab, Javier Sobrinoc,
Manuel Gorostidid, Ernest Vinyolese, Cristina Sierraf, Julian Segurag,
Antonio Cocaf and Luis Miguel Ruilopeg, for the Spanish Society of
Hypertension Ambulatory Blood Pressure Monitoring Registry InvestigatorsObjectives To assess the reproducibility of the circadian
blood pressure (BP) pattern over a 48-h period by
comparing the first 24 h of ambulatory blood pressure
monitoring (ABPM) with the following 24 h and with the
mean over 48 h.
Patients and methods Patients undergoing 48-h ABPM
within the National ABPM Registry of the Spanish Society of
Hypertension, based on 800 Spacelabs 90207 monitors
distributed throughout Spain in hypertension units and
primary healthcare centres, were included. Between June
2004 and September 2005, 611 valid 48-h ABPM recordings
were obtained, 235 corresponded to patients without
antihypertensive treatment.
Results The percentages of patientsclassifiedas non-dipper
for the first 24 h, the second 24 h and the 48-h average were
47, 50 and 48%, respectively. When the first and second
24-h periods were compared, 147 (24%) subjects switched
from dipper (D) to non-dipper (ND) or vice-versa. When the
first 24-h period was compared to the 48-h average, 66 (11%)
subjects switched patterns. The proportions were similar
separately for systolic blood pressure (SBP) and diastolic
blood pressure (DBP) and between treated and untreated
patients. In subjects with poor ABPM reproducibility, night-to-
day ratios were of an intermediate value between those of
subjects always classified as D or ND.opyright © Lippincott Williams & Wilkins. Unautho
0263-6352  2007 Wolters Kluwer Health | Lippincott Williams & WilkinsConclusion Categorization of D or ND based on a single
24-h ABPM is moderately reproducible, since one out of
every five patients change profile over the following 24 h.
Nevertheless, the use of 48-h ABPM in clinical practice
should be assessed according to cost-effectiveness criteria.
Night-to-day ratios may be helpful in identifying patients
with a stable profile. J Hypertens 25:2406–2412 Q 2007
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See editorial commentary on page 2377Introduction
Ambulatory blood pressure monitoring (ABPM) provides
information on blood pressure (BP) during the activities
of daily life and sleep, allowing the circadian BP profile
to be defined [1,2]. Cross-sectional studies have shown
that subjects with a non-dipper (ND) profile who do not
display nocturnal BP reductions, have more severe target
organ damage than dipper (D) subjects, whose nocturnal
BP is at least 10% lower than daytime levels. It has been
reported that ND have higher levels of urinary albumin
excretion [3,4], a greater progression of renal failure [5,6],
a higher prevalence of left ventricular hypertrophy [7]
and a greater likelihood of heart failure [8]. The ND
profile has also been associated with angiographic coron-
ary artery stenosis in men [9], an increased prevalence ofsilent cerebrovascular disease [10,11] and a higher rate of
ischaemic and haemorrhagic stroke [12]. Prospective
studies have indicated that ND have more cardiovascular
events than D [13–15], with respect to both hypertensive
and normotensive subjects [14]. Therefore, the 24-h
BP profile may be useful in assessing cardiovascular
risk [16].
The classification of patients as D or ND on the basis of a
single 24-h monitoring period should, however, be
approached with caution, since one of the main draw-
backs of the circadian BP profile is its limited reprodu-
cibility [7,17–19]. Although absolute values for 24-h,
daytime and night-time BP are reasonably reproducible
over a short period under the same conditions, therized reproduction of this article is prohibited.
CReproducibility of the circadian BP pattern Herna´ndez-del Rey et al. 2407circadian BP profile changes between 20 and 45% in
subjects in a second ABPM performed a few weeks or
months later [7,17,19,20]. The reliability of the circadian
BP profile classification is important due to its prognostic
implications. In addition, it has been reported that the
association between the ND profile and left ventricular
hypertrophy or microalbuminuria is stronger in patients
with a reproducible ND profile than in those with a
variable profile [7,21].
Given the limited reproducibility of a single 24-h ABPM,
the question is whether more prolonged BP recordings
could improve the reliability of the circadian BP pattern
classification. The main aim of this study was to analyse
the reproducibility of the circadian BP profile in 48-h
recordings, based on data from the National ABPM
Registry of the Spanish Society for Hypertension. The
first 24 h of recording were compared with the following
24 h and with the mean for the 48-h period. As a second-
ary objective, differences in the night/day ratio between
subjects whose circadian BP profile changed from the first
to the second 24-h period and those who did not
were compared.
Methods
Patients
Patients from the National ABPM Registry of the
Spanish Society of Hypertension were included.
Between June 2004 and September 2005, a total of
20 000 valid ABPM recordings according to the project
criteria were performed [22]. This study analysed
611 recordings from patients with 48-h ABPM. Inclusion
and exclusion criteria for the registry were defined by the
accepted indications for ABPM [23,24]: patients with
suspected white-coat hypertension, patients with vari-
able symptomatic hypertension over a 24-h period,
hypertensive patients at high cardiovascular risk, and
patients with treatment-resistant hypertension were
included. Patients could present concomitant indica-
tions for ABPM. Subjects with an arm circumference
of more than 42 cm, atrial fibrillation or other arrhythmias
that could interfere with BP recording were excluded.
National Ambulatory Blood Pressure Monitoring
Registry of the Spanish Society of Hypertension
The National ABPM Registry of the Spanish Society of
Hypertension is a healthcare, teaching and research pro-
ject based on the introduction throughout Spain of 800
ABPM devices (Spacelabs Medical, model 90207; Space-
Labs Inc., Redmond, Washington, USA) for use in daily
clinical practice by primary care professionals and special-
ists in hypertension. The monitors are connected by
Internet (www.cardiorisc.com) and linked to the case
report form, in which a minimum number of mandatory
variables are collected for each patient. Full details of the
registry are described elsewhere [22,25]. Following vali-
dation, the data set is integrated in a single registry.opyright © Lippincott Williams & Wilkins. UnauthAll clinical investigators participated in a 3-h seminar/
workshop, which provided training in the monitoring
technique, the indications for ABPM, and the use of
the technology platform.
The general information recorded in the case report form
included: reason for ABPM, sociodemographic data, vas-
cular risk factors and use of antihypertensive medication
during the previous 2 weeks and during ABPM (type of
drug, total daily dose and treatment regimen). Clinical
measurements of BP and heart rate were the mean of two
recordings obtained with a mercury sphygmomanometer
or a validated semi-automatic device, according to the
2003 guidelines of the European Society of Hypertension/
European Society of Cardiology [23].
Signed informed consent was obtained for all patients
included in the registry, which contains no identifiable
patient information, in compliance with Spanish law. The
project was approved by the corresponding clinical
research ethics committees and health authorities.
Ambulatory blood pressure monitoring
ABPM was preferentially performed on a normal day and
the cuff used was appropriate to the size of the arm. The
length of ABPM, type of cuff (normal or obese), and time
of sleep and waking for each 24-h monitoring period were
recorded. The interval between clinic BP measurement
and ABPM was no more than 4 weeks.
Recordings were considered valid according to the pro-
ject criteria when the percentage of valid readings was at
least 80% of the total and there was no hour for which no
readings were available. At least 14 measurements were
required during the period of activity and/or a minimum
of 7 during the rest period.
The 611 recordings analysed in this study corresponded
to patients who met the general quality criteria and had
daytime working hours and a night-time rest period of at
least between 0100 and 0500 h. The D profile was
defined as a reduction in systolic (SBP) and diastolic
blood pressure (DBP) of at least 10% during the night
compared with the period of activity [1]. All other sub-
jects were classified as ND. Day and night periods were
defined on the basis of the patient diary. The night/day
ratio of SBP and DBP was calculated for four groups:
subjects who maintained the same circadian BP profile in
both 24-h periods (D-D and ND-ND) and those whose
profile changed between the two periods (D-ND and
ND-D).
Statistical analysis
After an initial descriptive analysis, patients with and
without antihypertensive treatment were compared
according to the demographic, clinical and biochemical
variables recorded. Quantitative variables were tested fororized reproduction of this article is prohibited.
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Table 1 Demographic characteristics and cardiovascular risk factors in treated and untreated patients
Variable All (n¼611) Treated (n¼376) Untreated (n¼235) P value#
Age (years) 58 (13) 61 (12) 54 (13) <0.001
Sex, malea 341 (56) 203 (54) 138 (59) 0.252
Waist circumference (men>102 cm, women>88 cm) 99 (16) 87 (23) 12 (5) <0.001
BMI (kg/m2) 29 (5) 30 (5) 28 (4) <0.001
Diabetes 110 (18) 93 (25) 17 (7) <0.001
Smoking 95 (16) 49 (13) 46 (20) 0.029
Dyslipidaemiab 235 (38) 160 (43) 75 (32) 0.007
Cardiovascular disease 60 (10) 54 (14) 6 (3) <0.001
Values are mean (standard deviation). BMI, body mass index. a n (%). b Definition of dyslipidaemia was that of the European Society of Hypertension/European Society of
Cardiology guidelines 2003 [23]. # Statistical comparisons between treated and untreated patients.
Table 2 Ambulatory blood pressure: average blood pressure over
48 h and differences between the first and second 24-h monitoring
periods
Mean Standard deviation P valueM
SBP
48-h day 133 14
48-h night 120 15
DBP
48-h day 81 10
48-h night 69 10
SBP
1st 24-h day 134.1 14 <0.0005
2nd 24-h day 132.5 14
SBP
1st 24-h night 120.3 16 0.081
2nd 24-h night 119.9 15
DBP
1st 24-h day 81.1 11 <0.0005
2nd 24-h day 80.1 11
DBP
1st 24-h night 69.0 10 0.017
2nd 24-h night 68.5 10
DBP, diastolic blood pressure; SBP, systolic blood pressure. MComparing the first
24 h of BP monitoring with the following 24 h.normality and were compared between groups using the
Student’s t-test or the Mann–Whitney test. Differences
in qualitative variables between different groups of sub-
jects were analysed with the chi-squared test or Fisher’s
exact test. McNemar’s test was applied for the pairwise
comparison of the proportion of non-dippers between the
different monitoring periods.
Comparisons of 24-h day and night BP measurements
between the first and second 24-h periods were made with
the Student’s t-test for paired data or the Wilcoxon test.
The differences between the means of the night/day
ratios between the four groups of patients, defined on
the basis of change or stability of the circadian profile
between the two 24-h periods, were assessed by analysis
of variance; the Bonferroni adjustment was applied to
post-hoc group comparisons. A Bland and Altman
graphical technique was applied, by plotting the differ-
ence of night/day ratios between the first 24-h and the
second 24-h periods for each subject against their mean,
both for SBP and DBP ratios. Those differences of night/
day ratios between the two monitoring periods were used
to estimate a coefficient of repeatability for the whole
sample, and then separately for treated and untreated
patients [26].
The cut-off for statistical significance was P¼ 0.05. Data
were analysed using the SPSS statistical package, version
13.0 (SPSS Inc., Chicago, Illinois, USA).
Results
A total of 611 subjects were included, of which 235 (38.5%)
were not receiving drug treatment (64 of these untreated
patients were normotensive at the initial visit). The mean
age was 58 13 years, 341 (56%) were men, and the mean
baseline BP was 149 19/87 11 mmHg; the mean BP
was 150 20/86 12 mmHg for patients receiving anti-
hypertensive treatment and 146 16/89 10 mmHg for
untreated patients. SBP was significantly higher in patients
receiving treatment (P¼ 0.006), while DBP was higher
in untreated patients (P¼ 0.012). The mean heart
rate in treated and untreated patients was 74 12 and
74 11 bpm, respectively (P¼ 0.767). Patients not
receiving antihypertensive treatment were younger, less
obese and had fewer cardiovascular risk factors thanopyright © Lippincott Williams & Wilkins. Unauthothose receiving treatment, except for the rate of smoking
(Table 1). Among treated patients (n¼ 376), 35% were
on monotherapy, 28% were receiving two drugs and
37% three or more antihypertensive drugs. Antihyper-
tensive medication was administered in the morning
in 78% of treated patients, at bedtime in 11%, both in
the morning and night in 10%, and only two patients
had their medication distributed in three doses per day.
Ambulatory BP values over 48 h and during the first and
second day are shown in Table 2. The difference in BP
between the two periods of activity was 1.55 mmHg [95%
confidence interval (CI), 1.04–2.06; P< 0.0005] for SBP
and 0.98 mmHg (95% CI, 0.64–1.31; P< 0.0005) for
DBP. No significant differences in the values of SBP
were observed between the two nocturnal periods, while
a difference of 0.50 mmHg (95% CI, 0.09–0.90;
P¼ 0.017) was observed for DBP.
An ND pattern was observed in 47% of patients in the
first 24 h, 50% in the second 24 h (P¼ 0.248) and 48% for
the mean of 48 h (P¼ 0.712 when compared with the first
24-h period). The ND profile was more common in
treated than untreated patients, both for the whole
48-h period (55 versus 36%, P< 0.0005) and separately
for the first 24-h and second 24-h periods (Fig. 1).rized reproduction of this article is prohibited.
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Differences in the circadian blood pressure pattern between treated
and untreated patients.
Table 3 Changes in circadian blood pressure pattern in treated and
untreated patients between the first and second 24 h and between
the first 24 h and the mean of 48 h
Treatment status
First 24-h
monitoring Dipper Non-dipper
(i) Between the first and second 24 hc
Treateda (n¼376) Dipper 119 51
Non-dipper 44 162
McNemar’s test, P¼0.538
Untreatedb (n¼235) Dipper 122 30
Non-dipper 22 61
McNemar’s test, P¼0.332
(ii) Between the first 24 h and the mean of 48 hf
Treatedd (n¼376) Dipper 149 21
Non-dipper 19 187
McNemar’s test, P¼0.875
Untreatede (n¼235) Dipper 138 14
Non-dipper 12 71
McNemar’s test, P¼0.845
a 25% of treated patients (95 subjects¼51þ44) changed their circadian pattern
between first and second 24-h monitoring. b 22% of untreated patients (52
subjects¼30þ22) changed their circadian pattern between first and second
24-h monitoring. c Comparison of the % of changes between treated and untreated
patients: P¼0.377. d 11% of treated patients (40 subjects¼21þ19) changed
their circadian pattern between the first 24-h monitoring and the whole 48-h
period. e 11% of untreated patients (26 subjects¼14þ12) changed their circa-
dian pattern between the first 24-h monitoring and the whole 48-h period.
f Comparison of the % of changes between treated and untreated patients:
P¼0.869.
Fig. 2
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Changes in circadian blood pressure pattern. (a) Between the first and
second 24 h. 147 (24%) subjects shifted from dipper (D) to non-dipper
(ND) or vice-versa (P¼0.248). (b) Between the first 24 h and the mean of
48 h. 66 (11%) subjects shifted from D to ND or vice versa (P¼0.712).Office BP control (office BP less than 140/90 mmHg) was
achieved in 156 (25.5%) subjects. The proportion of ND
pattern in the whole 48-h period was 50.6% in patients
with BP control and 47.0% in those without BP control
(P¼ 0.436). Neither was there any statistically significant
difference in the proportion of ND between patients
with and without BP control when treated and untreated
subjects were analysed separately (treated patients:
57.6 versus 54.6%, P¼ 0.611; untreated patients: 40.6
versus 34.5%; P¼ 0.385).
When the reproducibility of the circadian BP profile was
analysed, comparison of the first and second 24-h periods
revealed that 66 individuals classified as D in the first 24 h
were classified as ND for the second 24 h, while 81 indi-
viduals changed from a classification of ND in the first
period to D in the second period. In total, the circadian
BP profile changed in 147 (24%) patients between the
two periods (Fig. 2a). The same analysis was performed
separately according to treatment status. Circadian BP
profile changed from one period to the other in 52 out
of 235 patients (22%) not receiving drug treatment, and
in 95 out of 376 treated patients (25%) (P¼ 0.377)
[Table 3(i)].
When the first 24-h period was compared with the mean
for the 48-h period, 31 individuals classified as D for the
first 24 h were classified as ND for the mean of 48 h, while
35 individuals classified as ND were classified as D for
the mean of 48 h. In total, the circadian BP profile
changed in 66 (11%) subjects (Fig. 2b). Neither was there
any statistical difference in the proportion of changes
according to the treatment status [P¼ 0.869, Table 3(ii)].
Table 4 shows the night/day ratios of SBP and DBP for
the mean of 48 h and each of the two 24-h periods for theopyright © Lippincott Williams & Wilkins. Unauthfour groups of patients. Night/day BP ratios for subjects
whose circadian profile changed differed significantly
from those of subjects with a stable profile. The night/
day ratio increased progressively in the following order:orized reproduction of this article is prohibited.
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Table 4 Night-to-day ratio according to the reproducibility of the circadian blood pressure pattern
Night-to-day ratio
All patients (n¼611) D-D (n¼241) D-ND (n¼81) ND-D (n¼66) ND-ND (n¼223)
SBP 48 h 0.840.04 0.900.03M 0.900.02M 0.980.06
DBP 48 h 0.790.05 0.850.03M 0.860.03M 0.930.07
SBP 1st 24 h 0.830.04 0.860.03MM 0.940.03M 0.980.06
SBP 2nd 24 h 0.840.05 0.940.05M 0.870.03M 0.980.07
DBP 1st 24 h 0.790.06 0.810.04# 0.900.05## 0.930.07
DBP 2nd 24 h 0.790.06 0.890.05M 0.820.04M 0.940.07
D, dipper; ND, non-dipper. ANOVA among the four groups of patients for all the night-to-day ratios considered: P<0.0005. Post-hoc comparisons: MP<0.0005, in the
post-hoc comparison both with D-D and with ND-ND groups. MMP¼0.002 in the post-hoc comparison with D-D and P<0.0005 in the comparison with ND-ND.
# P¼0.001 in the post-hoc comparison with D-D and P<0.0005 in the comparison with ND-ND. ## P<0.0005 in the post-hoc comparison with D-D and P¼0.002 in the
comparison with ND-ND.D-D, D-ND, ND-D, ND-ND. Thus, individuals whose
circadian profile changed had night/day ratios located
between those who were D or ND in both 24-h monitor-
ing periods. A similar pattern was observed when
untreated subjects were analysed (data not shown). When
graphically analysing the variability of SBP night/day
ratios between the first and second 24-h monitoring
periods, no systematic variation in the differences
between periods was observed over the range of the ratio
values, neither globally nor separately for treated and
untreated patients (Fig. 3); a similar plot was obtained for
DBP ratios.Fig. 3
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untreated patients, respectively.Discussion
The present clinical study compared the reproducibility
of the circadian BP profile between two consecutive 24-h
ABPM periods and with the mean for 48 h and found that
the circadian profile changed in 24% of individuals
between the two 24-h periods. This percentage was
reduced to 11% when the first 24-h period was compared
with a longer monitoring period, the mean of 48 h. These
changes in circadian BP profile occurred independently
of whether patients were receiving antihypertensive
treatment or whether the circadian profile was classified
as D or ND (Figs 2 and 3, Table 3).
The degree of reproducibility of the D or ND profile
was independent of treatment, confirming the results of
the SAMPLE study involving repeated monitoring
periods over 1 year in hypertensive patients before and
after treatment with lisinopril [17]. Mochizuki et al. [18]
also reported limited reproducibility of the circadian
BP profile recorded over a 48-h period: in 253 un-
treated hypertensive patients with no cardiovascular
complications, the profile changed in 29% of them
between the first and second day. Some studies have
found that the circadian BP profile is more reproducible
in groups of patients with a higher prevalence of non-
dipping pattern, as is the case of diabetic subjects [27] or
patients with kidney failure [28]. Although we observed
no differences in reproducibility according to the circa-
dian profile, only 18% of patients were diabetic and only
2% had renal failure.opyright © Lippincott Williams & Wilkins. UnauthoThe proximity of the two monitoring periods removed
the possibility of changes observed as a cause of environ-
mental conditions, such as changes in temperature, body
weight or treatment, factors that were not controlled in
other studies and can influence BP changes. Unlike our
study, where short-term reproducibility is analysed in
consecutive 24-h periods, most studies assessing the
reproducibility of ABPM compared monitoring periods
separated by weeks or months, sometimes with interven-
ing treatment, although the changes observed in the
circadian BP profile are similar to our results [7,17,19,21].rized reproduction of this article is prohibited.
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periods varied between 1 and 2 mmHg for the active
period, with lower values at night and for DBP in both
periods. These differences during the daytime fall in the
middle of the range reported by other authors [20,29] and,
in our opinion, are clinically irrelevant for a given subject.
Consequently, the use of repeated ABPM or ABPM for
periods longer than 24 h should probably be limited in
the clinical practice setting to those situations where
decisions are made based on BP circadian profile. Some
reports [20,29] have suggested that differences in BP
between consecutive days could be due to increased
BP during the first few hours of monitoring (‘the ABPM
effect’) on the first time that BP is monitored [30].
Although BP is a continuous variable, the reproducibility
of the circadian BP profile has mainly been assessed
qualitatively as D/ND. Prospective studies where BP
has been analysed as a continuous variable have shown
a continuous inverse relationship between increased car-
diovascular morbidity and mortality and a lower nocturnal
decline in BP [14,15]. It is probable that if BP were
assessed quantitatively as the night/day ratio, the repro-
ducibility would improve and this might allow better
identification of individuals with low reproducibility of
the circadian BP profile. Given the limitations of classify-
ing patients as D or ND, we decided to analyse the
circadian BP profile as a continuous variable in terms
of the night/day ratio, in an attempt to better identify the
group of subjects with poor reproducibility. We found
that the night/day BP ratio of subjects whose circadian
profile changed was significantly different to the ratio
of those with a stable profile, both for SBP and DBP
(Table 4). Subjects with low reproducibility of ABPM
recordings had a night/day BP ratio in both 24-h periods
that lay between patients who remained either D or ND.
Furthermore, the ratio in individuals with poor repro-
ducibility was closer to the cut-off of 0.9 that defines
the circadian BP profile. The variability around the cut-
off of the night/day SBP ratio (not the DBP ratio) is
mainly responsible for the change in the circadian profile
between the first and the second 24-h period.
Assessment of the circadian BP profile in terms of the
night/day BP ratio (especially for SBP) can help to
identify individuals whose profile is more reproducible.
Antihypertensive treatment does not affect the reprodu-
cibility of the circadian BP profile analysed according
to the night/day ratio (Fig. 3). BP variability, one of the
factors that may explain the poor reproducibility of
ABPM, is partly dependent upon physical activity, a
variable that may differ according to the day of measure-
ment; however, studies of simultaneous activity monitor-
ing do not appear to have found that changes in physical
activity explain the changes observed in the circadian BP
profile between monitoring periods [31,32]. Sleep quality
is another factor that could influence the classification asopyright © Lippincott Williams & Wilkins. UnauthD or ND, but not all authors agree that this variable
influences changes in the circadian BP profile [32].
Finally, the phenomenon of regression to the mean with
repeated BP should be taken into account [33].
Many of the factors involved in changes in the circadian
BP profile remain to be elucidated and the mechanisms
associated with a lack of reduction in the nocturnal BP
have not been fully identified; however, it is known that
the vascular system of these patients is exposed to a
greater haemodynamic load over a 24-h period, leading to
increased cardiovascular morbidity and mortality.
The limitations of the study include the clinical setting,
which means there were various reasons for performing
ABPM. In addition, the physical activity of the subjects
and the duration of the daytime and night-time periods
were only assessed using the patient diary; however,
some studies have shown a good correlation between
the hours of rest indicated in the patient’s diary and those
obtained from actigraph recordings [34], while others
have found that differences in BP between consecutive
monitoring periods are not accompanied by changes in
heart rate or physical activity measured by actigraph
[30,31]. Sleep quality was also not measured since patient
assessment of this variable is highly subjective; however,
patients who did not sleep for a minimum period (from
01.00 h to 05.00 h) or who worked during the night were
excluded. Possible variations in the timing of medication
were also not assessed, although in all the analyses, no
differences were observed in circadian profile variability
in the different periods between treated and untreated
subjects. Although daytime activity and the duration and
quality of sleep are the main determinants of the size of
the nocturnal BP reduction, other factors can affect the
variability of the circadian BP profile [35]. Finally, when
analysing our results, it should be remembered that
comparing the results from the first 24-h period and
the mean of 48 h means comparing a part with the whole,
and that the similarity is, consequently, always greater
than when comparing the first and second 24-h periods.
In conclusion, classification as D or ND on the basis of a
single 24-h ABPM period is moderately reproducible,
given that one in five patients change their profile in the
following 24-h period and one in 10 when compared to
the mean of the 48-h period. Our results, derived from the
analysis of two consecutive 24-h ABPM sessions, suggest
that a more reliable classification of the BP circadian
profile, at least when used for clinical decision making
(non-dippers), should be performed by repeating a sec-
ond ABPM within a short period.
Despite the proportion of incorrectly classified patients
being reduced with 48-h ABPM, its use in clinical prac-
tice should be further assessed in terms of cost-effective-
ness. Given that the reproducibility of ABPM is worse inorized reproduction of this article is prohibited.
C2412 Journal of Hypertension 2007, Vol 25 No 12patients with a night/day BP ratio closer to the cut-off that
defines the D/ND profile, identification of the factors
involved in the reproducibility of the circadian BP profile
is essential in order to more accurately classify individuals
as D/ND. Further studies using chronotherapeutic
approaches to antihypertensive treatment to determine
whether normalization of the circadian BP profile
improves cardiovascular prognosis in ND individuals
are necessary.
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